Given the current global situation with COVID-19, we want to reassure our customers that our policies allow us to ensure operational continuity. The Phenocell management team evaluates our measures as the situation evolves to provide mitigation of potential service disruptions to our customers while staying in compliance with national directives.

We do not anticipate any impact on our ability to continue to deliver products and services to our customers.

Move your R&D forward
with our innovative, efficient and cost-effective bioassays and cell models
Get in touch